Broadcom vs. SK Hynix: Which Technology Stock Is a Better Buy in 2026?

SK hynix generated FY2025 revenue of roughly $71.7B, up 46.8%, and net income of $31.7B, while its most recent quarter ended June 30, 2026 delivered 233% revenue growth amid AI-driven high-bandwidth-memory demand. It trades at a substantially lower 7.6x forward P/E versus Broadcom's 30.2x, with higher operating margin (nearly 68% versus about 49%) and free cash flow per share ($8.67 versus $8.07). The article favors SK hynix for aggressive AI exposure but stresses its memory-cycle volatility; Broadcom offers steadier, diversified infrastructure-software fundamentals despite $67.12B of debt, customer concentration, and legal/regulatory risks.

Analysis

The relevant relative-value question is not AI exposure but earnings durability. AVGO's software mix and custom-ASIC franchise should sustain a materially higher through-cycle multiple than a pure memory supplier, yet its premium leaves little tolerance for a slower hyperscaler capex cadence or integration-driven software churn. SK hynix offers stronger operating leverage to HBM tightness, but its low multiple embeds the market's expectation that extraordinary memory margins ultimately normalize; the catalyst path over the next 1-3 months is HBM contract-pricing commentary and evidence that supply additions from Samsung and Micron are delayed rather than merely difficult.

A less obvious beneficiary of sustained HBM scarcity is NVDA: constrained memory supply can protect accelerator system pricing and reinforce its qualified-supplier ecosystem, although it can also cap unit shipments if substrate, packaging, and HBM availability fail to scale together. TSM is the cleaner picks-and-shovels exposure because both merchant AI accelerators and AVGO custom silicon consume leading-edge foundry capacity; however, it is vulnerable to customer mix shifts rather than memory-price downside. AVGO's customer concentration should be viewed as a bargaining-power issue: large customers may accept design lock-in initially, then demand margin concessions once second-source custom silicon becomes viable.

Consensus may be too focused on SK hynix's headline valuation discount and insufficiently attentive to cycle timing. Memory equities typically de-rate before reported earnings weaken, so a forward multiple alone is not a margin-of-safety signal when spot or contract DRAM pricing rolls over. Conversely, AVGO's leverage is manageable only if recurring software cash flow remains resilient; a meaningful slowdown in VMware bookings, renewal rates, or AI semiconductor backlog conversion would expose both earnings estimates and its valuation premium over 6-18 months.

Key Decisions for Investors

• Prefer a 3-6 month pair: long AVGO / short SK hynix exposure (use the most liquid local listing or verified ADR rather than assuming SKHY is executable). This expresses durability over memory-cycle beta; target a 10-15% relative return, with a stop if HBM contract pricing continues to rise for two consecutive quarters while AVGO AI revenue/backlog conversion misses guidance.
• Maintain or initiate a 6-12 month long TSM as diversified AI-volume exposure, sized below AVGO because geopolitical risk is non-fundamental. The thesis is falsified by a leading-edge utilization decline, capex reduction, or customer inventory correction; use any post-results weakness rather than chasing AI-momentum highs.
• Do not add outright SK hynix solely on its low forward P/E. Upgrade to a tactical long only after independently verified HBM pricing, capacity, and customer qualification data show supply tightness extending at least two quarters; downside is a rapid multiple reset if conventional DRAM/NAND pricing turns.
• For AVGO, monitor VMware net retention, large-customer renewal behavior, and semiconductor backlog conversion at the next two earnings reports. Reduce exposure if software growth decelerates materially or management cuts AI-related revenue expectations, as those signals would challenge the cash-flow durability supporting the premium multiple.